XOMA Co. (NASDAQ:XOMAP) Short Interest Down 92.2% in April

XOMA Co. (NASDAQ:XOMAP) was the recipient of a large decline in short interest during the month of April. As of April 30th, there was short interest totaling 122 shares, a decline of 92.2% from the April 15th total of 1,568 shares. Based on an average daily volume of 7,126 shares, the short-interest ratio is presently 0.0 days.

XOMA Price Performance

NASDAQ:XOMAP traded down $0.12 during trading hours on Monday, reaching $25.26. 1,294 shares of the company traded hands, compared to its average volume of 2,152. XOMA has a 1-year low of $25.14 and a 1-year high of $30.00. The firm’s 50-day moving average is $25.97 and its 200-day moving average is $26.29.

XOMA Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Wednesday, April 15th. Investors of record on Thursday, April 2nd were paid a $0.5391 dividend. The ex-dividend date of this dividend was Thursday, April 2nd. This represents a $2.16 annualized dividend and a yield of 8.5%.

About XOMA

XOMA Corporation (NASDAQ: XOMAP) is a clinical-stage biopharmaceutical company focused on the discovery and development of therapeutic antibodies for autoimmune and inflammatory diseases. The company leverages proprietary antibody-generation technologies—including ribosome display and phage display—to identify and optimize human monoclonal antibodies with high specificity and favorable pharmacological profiles.

Its lead clinical program is an interleukin-1 beta modulator being evaluated in patients with rare and severe inflammatory conditions.